CT纹理分析联合术前临床因素预测肝细胞癌TACE早期疗效
本研究回顾性纳入92例TACE治疗的HCC患者,基于术前7天肝动脉期和门静脉期CT提取纹理特征并联合4项临床因素构建列线图,预测TACE后肿瘤活性状态。RadScore在训练集和测试集的AUC分别为0.881和0.88;列线图内部验证AUC训练集0.91、测试集0.889。列线图可作为多学科治疗决策的附加标准。
要点
- 术前增强CT纹理分析可预测HCC对TACE的早期反应。
- RadScore联合4项临床因素构建的列线图预测效能高(AUC>0.88)。
- 列线图可能辅助多学科团队制定TACE治疗决策。
核心结论
- 基于术前增强CT纹理特征和临床因素的列线图能高精度预测HCC病灶对TACE的早期反应,可能作为多学科治疗决策的附加标准。
研究设计与样本
- 回顾性研究,纳入2012年1月至2022年间92例接受TACE治疗且术前7天行肝脏增强CT、临床信息完整的HCC患者。
关键影像表现/征象
- 从基线动脉期和门静脉期CT图像上提取最大肿瘤的定量纹理参数和临床因素。
诊断标准与关键数值
- RadScore预测肿瘤活性的AUC:训练集0.881(95%CI 0.799-0.963),测试集0.88(95%CI 0.726-1)。
- 列线图内部验证AUC:训练集0.91(95%CI 0.837-0.984),测试集0.889(95%CI 0.746-1)。
- 测试集中列线图总分是显著预测因子(P=0.034),训练集拟合良好(P=0.833)。
临床应用与阅片要点
- 术前可基于增强CT动脉期和门静脉期纹理分析计算RadScore,结合临床因素评估TACE早期疗效风险。
局限性
- 回顾性研究,样本量92例,单中心,需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To investigate a pre-therapeutic radiomics nomogram to accurately predict hepatocellular carcinoma (HCC) lesion responses to transcatheter arterial chemoembolization (TACE).
METHODS: This retrospective study from January 2012 to 2022 included 92 TACE-treated patients who underwent liver contrast-enhanced CT scan 7 days before treatment, having complete clinical information. We extracted quantitative texture parameters and clinical factors for the largest tumors on the baseline arterial and portal venous phase CT images. An adaptive least absolute shrinkage and selection operator (LASSO)-penalized logistic regression identified independent predictors of tumor activity after TACE.
RESULTS: We fitted an adaptive LASSO regression model to narrow down the texture features and clinical risk factors of the tumor activity status. The selected texture features were used to construct radiomic scores (RadScore), which demonstrated superior performance in predicting tumor activity on both the training (area under the curve (AUC): 0.881, 95% CI: 0.799-0.963) and testing sets (AUC: 0.88, 95% CI: 0.726-1). A logistic regression-based nomogram was developed using RadScore and four selected clinical features. In the testing set, nomogram total points were significant predictors (P = 0.034), and the training set showed no departure from perfect fit (P = 0.833). Internal validation of the nomogram was obtained for the training (AUC: 0.91, 95% CI: 0.837-0.984) and testing (AUC: 0.889, 95% CI: 0.746-1) sets.
CONCLUSION: We propose a nomogram to predict the early response of HCC lesions to TACE treatment with high accuracy, which may serve as an additional criterion in multidisciplinary decision-making treatment.
引用
- Fan, Wang, Chen, et al. Computed tomography texture analysis combined with preoperative clinical factors serve as a predictor of early efficacy of transcatheter arterial chemoembolization in hepatocellular carcinoma. Abdom Radiol (NY). 2023. PMID: 36943423. doi:10.1007/s00261-023-03868-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。